Parallel Advisors »

Larimar Therapeutics shares owned by Parallel Advisors

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $735 193 3.81

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Microsoft Stock (MSFT)
Corcept Therapeutics Stock (CORT)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Amazon.com Stock (AMZN)
Cvb Finl Corp Stock (CVBF)
Janus Henderson Mortgage-backed Securities Etf Etf (JMBS)
Vanguard Large Cap Etf (VV)
Avantis International Equity Etf Etf (AVDE)
Ishares Core Msci Eafe Etf Etf (IEFA)

View all positions for Parallel Advisors

Top funds holding Larimar Therapeutics

Deerfield Management Company
Blue Owl Capital Holdings
RA Capital Management
Millennium Management
BlackRock
Rtw Investments
Vanguard Group
AIGH Capital Management
Adage Capital Partners GP
Citadel Advisors
Point72 Asset Management
Goldman Sachs Group
Geode Capital Management
DAFNA Capital Management
Alyeska Investment Group

View all funds holding Larimar Therapeutics